Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

NCT06424470 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Prurigo Nodularis

Interventions

BIOLOGICAL: Stapokibart
OTHER: Placebo

Sponsor

Keymed Biosciences Co.Ltd